| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/16/2005 | EP1506186A1 Substituted heterocyclic compounds and methods of use |
| 02/16/2005 | EP1506180A1 Thiazolidine-4-one derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 02/16/2005 | EP1506174A2 Opioid and opioid-like compounds and uses thereof |
| 02/16/2005 | EP1506167A1 Hydroxy tetrahydro-naphthalenylurea derivatives |
| 02/16/2005 | EP1506166A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
| 02/16/2005 | EP1506162A2 Synthesis of benzonitriles and benzimidates |
| 02/16/2005 | EP1506011A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 02/16/2005 | EP1506002A2 Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies |
| 02/16/2005 | EP1505992A1 Method for reducing pain using oncolytic viruses |
| 02/16/2005 | EP1505984A2 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury |
| 02/16/2005 | EP1505983A2 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 02/16/2005 | EP1505982A1 Trimegestone and estrogens for treating post menopausal disorders |
| 02/16/2005 | EP1505979A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles |
| 02/16/2005 | EP1505973A2 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 02/16/2005 | EP1505970A1 Methods of using thiazolidine derivatives to treat cancer or inflammation |
| 02/16/2005 | EP1505968A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes |
| 02/16/2005 | EP1505930A2 Drug-delivery endovascular stent and method for treating restenosis |
| 02/16/2005 | EP1425258A4 Hydroxyeicosenoic acid analogs |
| 02/16/2005 | EP1397365B1 Heteroaryl-diazabicyclo-alkanes as cns-modulators |
| 02/16/2005 | EP1395553B1 Pyrrolidine derivatives as factor xa inhibitors |
| 02/16/2005 | EP1296698A4 Therapeutic agents - ii |
| 02/16/2005 | EP1296697A4 Therapeutic agents - i |
| 02/16/2005 | EP1281709B1 Novel heterocyclic compounds with anti-inflammatory activity |
| 02/16/2005 | EP1246814B1 Compounds and methods for modulation of estrogen receptors |
| 02/16/2005 | EP1240166B1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl carboxamide inhibitors of cyclin dependent kinases |
| 02/16/2005 | EP1215203B1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
| 02/16/2005 | EP1207898B1 Treatment of conjunctivitis by histacalin proteins |
| 02/16/2005 | EP1068200B1 2,4,4-trisubstituted-1,3-dioxolane antifungals |
| 02/16/2005 | EP0957926B1 Oligonucleotide compositions and methods for the modulation of the expression of b7 protein |
| 02/16/2005 | EP0634896B1 Evaluation of patients with progressive immunosuppression |
| 02/16/2005 | CN1582522A Intelligent serial cell charger and charging circuit block |
| 02/16/2005 | CN1582301A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/16/2005 | CN1582288A Heteroaryl derivatives as superior ligands for nociceptin receptor ORL-1 |
| 02/16/2005 | CN1582287A Thiophenylthiopyrane dioxides as MMP or TNF-alpha inhibitors |
| 02/16/2005 | CN1582285A Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (GSK3 inhibitors) |
| 02/16/2005 | CN1582284A Aminopyrimidines and pyridines |
| 02/16/2005 | CN1582283A Benzothiepine ileal bile acid transport inhibitors |
| 02/16/2005 | CN1582277A Amide derivatives as glycogen synthase kinase 3-beta inhibitors |
| 02/16/2005 | CN1582276A Phenylalanine enamide derivatives |
| 02/16/2005 | CN1582275A Calcium antagonistic compound |
| 02/16/2005 | CN1582271A Inhibitors of integrin alpha v beta 6 |
| 02/16/2005 | CN1582269A Hydroxyeicosenoic acid analogs |
| 02/16/2005 | CN1582172A Treating canker sores with patches to speed healing and relieve pain |
| 02/16/2005 | CN1582169A Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions |
| 02/16/2005 | CN1582161A Pharmatceutical Formualtion comprising cyclosporin and use thereof |
| 02/16/2005 | CN1582158A Novel therapeutic indication of azithromycin for treatment of non-infective inflammatory diseases |
| 02/16/2005 | CN1582148A Derivatives of phenoxy-n-'4-(isothiazolidin-1, 1-dioxid-2yl)pheny!-valerian- acid amide and other compounds as inhibitors of the coagulation factor Xa in the treatment of thromboembolic diseases and tu |
| 02/16/2005 | CN1582142A Ibuprofen salt emulsifiers and cream formulations containing same |
| 02/16/2005 | CN1580077A Echinacea polysaccharide, and its preparing method and use for preparing medicines for treating antivirus and antibacterial, especially anti SARS |
| 02/16/2005 | CN1580064A Tangeritin extracting technique |
| 02/16/2005 | CN1580049A Method for extracting total phenyl phthalein of ligusitcum wallichii |
| 02/16/2005 | CN1579542A Lugua polypeptides for injection and its preparing process |
| 02/16/2005 | CN1579541A Compound bone peptide for injection and its preparation process |
| 02/16/2005 | CN1579540A Gugua polypeptides for injection and its preparing method |
| 02/16/2005 | CN1579528A Soft capsule of expelling toxin by cooling and its preparation method |
| 02/16/2005 | CN1579517A Quick-acting medicated liquor for treating traumatic injury |
| 02/16/2005 | CN1579492A Resina draconis and its total flavone solution preparation and its preparation method |
| 02/16/2005 | CN1579490A Traditional Chinese medicinal preparation for women's menalgia |
| 02/16/2005 | CN1579484A Traditional Chinese medicine pain-relieving bag |
| 02/16/2005 | CN1579476A Precription of traditional Chinese medicine for treating gynaecological disease, its use and preparation method |
| 02/16/2005 | CN1579471A Bizhengkang-treating arthromyodynia |
| 02/16/2005 | CN1579463A Compound cape-jasmine salted-fermented beans total extract and its preparation and use |
| 02/16/2005 | CN1579453A Anti-rheumatism medicated spirit for treating rheumatic arthritis and rheumatoid arthritis |
| 02/16/2005 | CN1579450A She medicinal composition for treating bone fracture and relieving pain, and its cataplasm and preparation process thereof |
| 02/16/2005 | CN1579439A Numbness-activating blood-circulation-promoting pain-relieving ointment |
| 02/16/2005 | CN1579438A Inflammation-eliminating and pain-relieving shengji ointment |
| 02/16/2005 | CN1579431A Cool cream |
| 02/16/2005 | CN1579429A Pain-relieving medicine |
| 02/16/2005 | CN1579414A Glossy-ganoderma-spore polysaccharide for injection and its preparation process |
| 02/16/2005 | CN1579408A Medicine for spasmolysis and relieving pain and preparation method |
| 02/16/2005 | CN1579387A Extraction of protopine from plant, and its manufacture of medicinal preparation and use |
| 02/16/2005 | CN1579385A New Preparation of Gantaile |
| 02/16/2005 | CN1579380A Decanoy-acetaldehyde sodium frozen-dry powder injecta and preparation method |
| 02/16/2005 | CN1579372A Essence-oil soft capsule and its preparation method |
| 02/16/2005 | CN1579371A Fructus-amomi wind-repellent soft capsule and preparation method |
| 02/16/2005 | CN1579369A Cuyantong slow-releasing round-particle composition and preparation method |
| 02/16/2005 | CN1189560C Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria |
| 02/16/2005 | CN1189484C Recombined human CD11a monclone antibody and its preparation and medicinal composition |
| 02/16/2005 | CN1189477C Bicyclic tachykinins antagonists, preparation thereof and their use in autagonistes composition |
| 02/16/2005 | CN1189467C Pharmaceutically active sulfonamide derivatives |
| 02/16/2005 | CN1189459C Pyrazoline derivatives, their prep. and application as medicaments |
| 02/16/2005 | CN1189214C Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors |
| 02/16/2005 | CN1189208C Chinese medicine composition for curing child common cold fever |
| 02/16/2005 | CN1189197C Traditional Chinese medicine having effects of reducing inflammation, stopping blooding, stopping pain, promting blood circulation and promoting tissue regeneration |
| 02/16/2005 | CN1189186C Antiphlogistic and analgesic ointment for treating rheumatism and trauma |
| 02/16/2005 | CN1189170C Thienylazolylal coxyethanamines, their preparation and their application as medicaments |
| 02/16/2005 | CN1189166C FC receptor modulators and uses thereof |
| 02/16/2005 | CN1189165C Fast-acting analgesic |
| 02/16/2005 | CN1189164C Rolled external-use patch |
| 02/15/2005 | US6855843 Antihistamines; rheumatic diseases; antidiabetic agents; inflammatory bowel disorders |
| 02/15/2005 | US6855806 Comprises secreted polypeptide for diagnosis and treatment of tumors, nervous system, reproductive and muscular disorder |
| 02/15/2005 | US6855722 Substituted indoles and their use as integrin antagonists |
| 02/15/2005 | US6855719 Nitrogen compounds such as 2-(3-Chloroanilino)-4-(2-methyl-imidazo(1,2a)pyrid-3-yl)pyrimidine, used as cyclin dependent kinase inhibitors or as anticarcinogenic agents |
| 02/15/2005 | US6855706 Phenylalanine derivatives |
| 02/15/2005 | US6855532 Gene therapy; drug screening |
| 02/15/2005 | US6855528 Administering a covalently reactive antigen analog (CRAA) having an an epitope recognized irreversibly bound by catalytic antibody; autoimmune disease; a lymphoproliferative disorder; anticarcinogenic, -tumor, -inflammatory agents |
| 02/15/2005 | US6855512 Phenylacetic or heteroarylacetic acid derivatives; retinoid like activity |
| 02/15/2005 | US6855350 Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract |
| 02/15/2005 | US6855310 Aerosol for inhalation therapy, wherein the aerosol comprises particles comprising at least 10 percent by weight of acetaminophen, orphenadrine or tramadol. |
| 02/15/2005 | CA2421026C Viral inhibition by n-docosanol |